Literature DB >> 17172986

The disaccharide trehalose inhibits proinflammatory phenotype activation in macrophages and prevents mortality in experimental septic shock.

Letteria Minutoli1, Domenica Altavilla, Alessandra Bitto, Francesca Polito, Ersilia Bellocco, Giuseppina Laganà, Daniela Giuliani, Tiziana Fiumara, Salvatore Magazù, Pietro Ruggeri, Salvatore Guarini, Francesco Squadrito.   

Abstract

Proinflammatory phenotype activation in macrophages (MPhis) after sepsis orchestrates an inflammatory response leading to multiple organ dysfunction. Trehalose preserves cell viability during exposure to a range of environmental stresses. We investigated whether trehalose may inhibit endotoxin-induced activation of the inflammatory phenotype in MPhis. Rat peritoneal MPhis were stimulated with 50 microg/mL of Salmonella enteritidis lipopolysaccharide (LPS). Stimulated MPhis were coincubated with trehalose (25, 50, and 100 mmol), sucrose (100 mmol), or RPMI alone. Macrophages cultures were used for Western blot analysis of extracellular-regulated kinase, c-jun-N terminal kinase, and inducible nitric oxide synthase; interleukin (IL) 1beta, IL-6, and tumor necrosis factor alpha (TNF-alpha) gene expression by real-time reverse transcriptase-polymerase chain reaction, and supernatants for measuring the release of inflammatory cytokines and nitrite content. In vitro trehalose significantly blunted LPS-induced extracellular-regulated kinase (LPS = 21 +/- 6 integrated intensity; LPS + trehalose 100 mmol = 2 +/- 0.3 integrated intensity), c-jun-N terminal kinase (LPS = 15 +/- 5 integrated intensity; LPS + trehalose 100 mmol = 3.5 +/- 0.9 integrated intensity), and inducible nitric oxide synthase activation (LPS = 12 +/- 3 integrated intensity; LPS + trehalose 100 mmol = 1 +/- 0.09 integrated intensity), blunted IL-1beta (LPS = 5 +/- 1.9 n-folds/beta-actin; LPS + trehalose 100 mmol = 1.5 +/- 0.8 n-folds/beta-actin), IL-6 (LPS = 4 +/- 1.5 n-folds/beta-actin; LPS + trehalose 100 mmol = 1.4 +/- 0.5 n-folds/beta-actin), and TNF-alpha (LPS = 4.2 +/- 1.6 n-folds/beta-actin; LPS + trehalose 100 mmol = 1.1 +/- 0.7 n-folds/beta-actin) gene expression, and markedly reduced the release of inflammatory cytokines and nitrite content. Furthermore, in vivo trehalose prevented mortality in rats challenged with a lethal dose (20 mg/kg; LD90) of LPS (80% survival rate and 70% survival rate 24 and 72 h after LPS injection, respectively) and reduced serum TNF-alpha. Sucrose did not modified inflammatory phenotype in vitro nor in vivo protected against endotoxin-induced mortality. Our study suggests that trehalose inhibits proinflammatory phenotype activation in MPhis and prevents endotoxin-induced mortality.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17172986     DOI: 10.1097/01.shk.0000235092.76292.bc

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  17 in total

1.  Trehalose attenuates spinal cord injury through the regulation of oxidative stress, inflammation and GFAP expression in rats.

Authors:  Mahdieh Nazari-Robati; Mahboobe Akbari; Mohammad Khaksari; Moghaddameh Mirzaee
Journal:  J Spinal Cord Med       Date:  2018-12-04       Impact factor: 1.985

2.  Favorable effects of trehalose on the development of UVB-mediated antioxidant/pro-oxidant imbalance in the corneal epithelium, proinflammatory cytokine and matrix metalloproteinase induction, and heat shock protein 70 expression.

Authors:  Jitka Cejková; Taras Ardan; Cestmír Cejka; Jacques Luyckx
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-15       Impact factor: 3.117

3.  Urban living in healthy Tanzanians is associated with an inflammatory status driven by dietary and metabolic changes.

Authors:  Godfrey S Temba; Vesla Kullaya; Tal Pecht; Blandina T Mmbaga; Anna C Aschenbrenner; Thomas Ulas; Gibson Kibiki; Furaha Lyamuya; Collins K Boahen; Vinod Kumar; Leo A B Joosten; Joachim L Schultze; Andre J van der Ven; Mihai G Netea; Quirijn de Mast
Journal:  Nat Immunol       Date:  2021-02-11       Impact factor: 25.606

Review 4.  Trehalose as a promising therapeutic candidate for the treatment of Parkinson's disease.

Authors:  Masoomeh Khalifeh; George E Barreto; Amirhossein Sahebkar
Journal:  Br J Pharmacol       Date:  2019-03-27       Impact factor: 8.739

5.  Co-lyophilized Aspirin with Trehalose Causes Less Injury to Human Gastric Cells and Gastric Mucosa of Rats.

Authors:  Lee-Shuan Lin; Yuko Kayasuga-Kariya; Shugo Nakamura; Nobuyuki Shimohata; Takamasa Sakai; Ayano Fujisawa; Yuki Akagi; Shigeki Suzuki; Ung-Il Chung; Nobuo Sasaki; Manabu Mochizuki
Journal:  Dig Dis Sci       Date:  2016-05-31       Impact factor: 3.199

6.  Trehalose alleviates PC12 neuronal death mediated by lipopolysaccharide-stimulated BV-2 cells via inhibiting nuclear transcription factor NF-κB and AP-1 activation.

Authors:  Qing He; Ying Wang; Wei Lin; Qiong Zhang; Jue Zhao; Feng-Tao Liu; Yi-Lin Tang; Bao-Guo Xiao; Jian Wang
Journal:  Neurotox Res       Date:  2014-08-15       Impact factor: 3.911

7.  Trehalose prevents glyphosate-induced hepatic steatosis in roosters by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.

Authors:  Cai-Yu Lian; Run-Zhou Wang; Jie Wang; Zhen-Yong Wang; Wei Zhang; Lin Wang
Journal:  Vet Res Commun       Date:  2022-10-20       Impact factor: 2.816

8.  Delineating the relationships among the formation of reactive oxygen species, cell membrane instability and innate autoimmunity in intestinal reperfusion injury.

Authors:  Haekyung Lee; Eun Hee Ko; Mark Lai; Na Wei; Javi Balroop; Zerin Kashem; Ming Zhang
Journal:  Mol Immunol       Date:  2013-12-22       Impact factor: 4.407

9.  Trehalose treatment suppresses inflammation, oxidative stress, and vasospasm induced by experimental subarachnoid hemorrhage.

Authors:  Ryosuke Echigo; Nobuyuki Shimohata; Kensuke Karatsu; Fumiko Yano; Yuko Kayasuga-Kariya; Ayano Fujisawa; Takayo Ohto; Yoshihiro Kita; Motonao Nakamura; Shigeki Suzuki; Manabu Mochizuki; Takao Shimizu; Ung-Il Chung; Nobuo Sasaki
Journal:  J Transl Med       Date:  2012-04-30       Impact factor: 5.531

10.  Therapeutic efficacy of trehalose eye drops for treatment of murine dry eye induced by an intelligently controlled environmental system.

Authors:  Jinyang Li; Christophe Roubeix; Yu Wang; Shuai Shi; Guoting Liu; Christophe Baudouin; Wei Chen
Journal:  Mol Vis       Date:  2012-02-04       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.